Life Sciences Organization Presentation
Transcription
Life Sciences Organization Presentation
NXL Architects is one of Canada’s leading architects for the design of complex process buildings. The firm has 20 years and more than 4 million square feet experience in GMP, Laboratory and Vivaria facilities. We are specialized. The firm has evolved since 1960, and the current partnership was formed in 1998. Since that time the firm has focused exclusively on the highly specialized research and production industry. We design from the inside out. We g f provide a tailored solution that ensures your building fits your specialized needs. We compete on service. From concept to completion ‐ we are there for the project and the client from the very beginning to the very end. the very beginning to the very end. About NXL Architects Expertise Studies and Masterplans Expertise Programming ORC Forensic Services 2007 Institutional Projects 1 2 1 3 4 1. York U Life Sciences Building 2. Biovail Steinbach Expansion 3. UHN TMDT 4. Patheon Whitby 5. Hemosol Meadowpine Facility 6. York SHSRC 5 6 Expertise Full Scope Services 1 2 1. UToronto Leslie L Dan Pharmacy Building 4. York U Life Sciences Building 2. Patheon Whitby 5. Syn X Discovery Labs 3 UHN TMDT @ MaRS 3. UHN TMDT @ MaRS 6 York U SHSRC 6. York U SHSRC 4 3 5 6 Expertise Laboratory Design Manufacturing Types Design for Manufacturing & Equipment Installations 2 1 3 Biopharmaceutical Biologics Monoclonal antibodies Monoclonal antibodies Mammalian & bacteria cell culture Clean rooms API manufacturing Contract manufacturing Oral solid dosage/ penicillin g /p Liquids Creams/ointments/gels Sterile ophthalmic Hormone manufacturing Vaccines 4 1. Patheon Whitby 2 Stuart Energy 2. Stuart Energy 3. Torcan Chemical Ltd. 4. UHN TMDT (NMR Room) 5. Alphora 6. Hemosol Inc 5 6 Expertise Facilities for Specialized Manufacturing and Equipment Looking Ahead 1 2 1. Hemosol 2 UHN Pathology 2. UHN Pathology 3. UHN TMDT Sterilization Suite 4. UHN TMDT Microarray 3 4 Expertise Specialized Environments 1 2 3 4 1. SPECT 4. Animal Holding Room 2. Cage Racking 5. Tunnel Washer 3. Animal OR 6. CT Scanner 5 6 Expertise Vivaria – Multi‐Species 1. UHN TMDT 2. York U Life Sciences Building 3. UHN KDC 4. Merck Frosst at MaRS 5. UHN KDC 6. Biovail Steinbach 7. UHN TMDT 1 2 3 5 4 6 7 Expertise Environments for Interaction • • • • • • • • • • • • • • • • • Alphora Research Inc. Astra Zeneca Canada Inc. Avecia Biotechnology Aventis Pasteur Limited Bioniche h Life Sciences Inc. f Biovail Corp. Core Cryolabs Credit Valley Hospital Cytochroma Inc. Estee Lauder Companies GeneNews GlaxoSmithKline Hemosol Merck Frosst Canada & Co. Microbix Novocol Pharmaceuticals Novopharm Ltd. • • • • • • • • • • • • • • • • • • NPS Pharmaceuticals Office of the Chief Coroner of Ontario Ontario Institute for Cancer Research Patheon Inc. Pfizer Canada Inc. f d Smithsonian Institute Stuart Energy Systems Syn X Pharma Inc. Taro Pharmaceuticals Teledyne‐Dalsa Therapure TM Biosciences Torcan Chemical Ltd. University Health Network University of British Columbia University of Toronto University of Windsor York University Clients Looking Ahead NXL works in both the public and private sector – taking lessons learned and top concerns from one area and applying to the other so that both sectors have the benefit of our expertise Industry / Academic CLIENTS Astra Zeneca Canada Inc. Avecia Biotechnology Aventis Pasteur Limited Bioniche Life Sciences Inc. Biovail Corp. GlaxoSmithKline Merck Frosst Canada & Co. Novopharm Ltd. Ltd 1 3 2 1. Novopharm Ltd. 2. Patheon Inc. 3. Glaxo Smith Kline 2 1 1 Pharmaceutical Projects Hemosol 2003 Looking Ahead Therapure 2011 Hemosoll H 2001 ORC/OAHPP Programming and Planning Study Commercial Scale Facility Projects SYN X Pharma R&D Facility Looking Ahead 2005 Gutted 2011 ORC/OAHPP Programming and Planning Study Commercial Scale Facility Projects Cytochroma Inc R&D Facility Looking Ahead 2004 Vacated 2011 Queen St West Commercial Development ORC/OAHPP Programming and Planning Study Commercial Scale Facility Projects Looking Ahead GeneNews R&D Facility 2007 Downsized D i d 2010 Queen St West Commercial Development ORC/OAHPP Programming and Planning Study Commercial Scale Facility Projects Alphora Kilo Lab / Pilot Plant / Masterplanning Looking Ahead 2009 / 2011 Commercial Scale Facility Projects University of Toronto Faculty of Pharmacy 2005 Institutional Projects UHN Pathology 2005 Institutional Projects UHN TORONTO MEDICAL UHN TORONTO MEDICAL DISCOVERY TOWER 2006 Institutional Projects NPS 2005 OICR 2008 Institutional Projects Sherman Health Sciences Research Centre York University 2010 50,000 sf $11.5M Adaptive Reuse / Full Interior Reno / New Entrance / New Mezzanine / Multiple User Groups Institutional Projects Credit Valley 2011 Institutional Projects Life Sciences Building York University 2011 200,000 sf $66M New Build / Fast Track Schedule Research & Teaching Labs/ Public Spaces / Part of existing campus Institutional Projects Krembil Discovery Centre at Toronto Western University Health Network 2013 Overall Project 330 000 sf $118M 330,000 sf $118M Research Component 175,000 sf $45M (approx) Fit‐out of Research and Collaborative Areas Programming, Design and Construction and Construction Institutional Projects Attracting research to Toronto TBI 2003 MaRS Tower A • NA’s largest combined bio‐medical cluster Looking Ahead • pharmaceutical pharmaceutical, medical research, medical research biotechnology, medical devices, medical surgical supply, and medical assistive technologies. • Employs 140,000. • NA’s 4th largest medical research community • 9,000 principal researchers and technicians • 37 37 research institutes and 9 teaching h i tit t d 9 t hi hospitals. • TO’s biotechnology cluster ranked among the world’s top 10. • Pharmaceutical industry in the GTA employs 11,000. • Sanofi Pasteur facility produces and ships vaccines to over 90 countries vaccines to over 90 countries. ORC/OAHPP Programming and Planning Study Where we are now Toronto’s “Discovery District” Toronto’s “Discovery District” • Research Research spin spin‐off off • Post‐incubator / pre‐commercial scale • Life science real estate industry if i l i d